The company sold 3,91,310 units in July 2023, compared to 4,45,580 units last year.
The project is expected to be completed within 30 months from the date of the Letter of Intent, with a target completion date of January 2026.
July sales rose 32 % year-on-year to 73,117 units.
Recommendation: Buy; Target price: Rs 300
The primary factor contributing to the lower sales was a significant 15% drop in two-wheeler dispatches
As per the agreement, Ravi Sanghi & family will sell their 56.74% stake in SIL to Ambuja Cements, a division of Adani Cement
Grover stated to ET, "We feel we have a formidable combination of levers to help us overcome any such competition.
The USFDA has given Zydus Lifesciences the go-ahead to produce and sell 50mg of Indomethacin suppositories.
This negative sentiment extended to the broader markets for the second consecutive session.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
